The best patient guide on clinical trials for anxiety disorders
Featured Studies
Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.
- AZD2327 to Treat Anxious Major Depression.
Interventional study. This study will examine the safety and effectiveness of an experimental drug called AZD2327 for treating anxious major depressive disorder. Ages 18-65. Location in Bethesda, MD.
- Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults.
Interventional study. This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder. Ages 60 and over. Locations in San Diego, CA; St. Louis, MO; Pittsburgh, PA.
- Cognitive Behavior Therapy for Treating Anxiety in People With Dementia.
Interventional study. This study will evaluate the effectiveness of cognitive behavioral therapy in treating anxiety in older adults with dementia. Ages 60 and over. Location in Houston, TX.
- Effectiveness of a School-Based Cognitive Behavior Therapy in Treating African American Children With Anxiety Disorders.
Interventional study. This study will determine the effectiveness of a school-based cognitive behavior therapy in African American children diagnosed with an anxiety disorder. Ages 7-12. Location in Baltimore, MD.
- Evaluating the Effects of Stress in Pregnancy.
Evaluation study. This study will evaluate pregnant women with a past or current diagnosis of depression or anxiety to gain a better understanding of how these disorders can affect an infant's development, both during and after pregnancy. Ages 18-45. Location in Atlanta, GA.
- Pharmacogenomics of Antidepressant Response in Children and Adolescents.
Evaluation study. This study will identify variations in genes that may be involved in the development of suicidal events or certain behaviors in youth who are exposed to antidepressant medications. Ages 7-17. Location in Durham, NC.
- Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders.
Evaluation study. This study will look at similarities and differences in family processes and child temperament among children with and without symptoms of anxiety disorders. Ages 8-12. Location in Providence, RI.
- Effect of D-Cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia.
Interventional study. This study will assess the effectiveness of D-cycloserine combined with cognitive-behavior therapy in treating people with social anxiety disorder. Ages 18 and over. Location in Boston, MA.
- Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias.
Interventional study. This study will compare the effectiveness of two types of cognitive behavioral therapy, one-session exposure treatment and family-enhanced one-session exposure treatment, in treating children with specific phobias. Ages 7-12. Location in Blacksburg, VA.
- Antidepressant Safety in Kids Study.
Evaluation study. This study will evaluate the risks and benefits of treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in children and adolescents with a pre-specified anxiety disorder, depressive disorder, eating disorder, or obsessive-compulsive disorder. Ages 7-17. Location in Durham, NC.
- Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy.
Interventional study. This study will evaluate the impact of interpersonal psychotherapy on the course of depression during and after pregnancy, as well as its effect on infant birth outcomes. Ages 21-45. Location in Ann Arbor, MI.
- Comparison of Psychotherapy Programs to Treat Panic Disorder.
Interventional study. This study will determine the relative effectiveness of three psychotherapies in treating people with a panic disorder. Ages 18-70. Locations in New York, NY; Philadelphia, PA.
- Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR.
Interventional study. This study will assess the effectiveness of venlafaxine XR in preventing the relapse of generalized anxiety disorder after 6 months of treatment versus 12 months of treatment. Ages 18 and over. Location in Philadelphia, PA.
- Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence.
Interventional study. This study will determine whether trauma-focused cognitive behavioral therapy (TF-CBT) is more effective than child-centered therapy (CCT) in reducing post traumatic stress disorder (PTSD) in children exposed to domestic violence (DV). Ages 7-14. Location in Pittsburgh, PA.
Dr. Jeffrey Speller
Dr. Tanya Korkosz
Psychopharmacology Associates of New England
Comments